naltrexone XR injection
Selected indexed studies
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. (Lancet, 2018) [PMID:29150198]
- Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial. (JAMA Netw Open, 2024) [PMID:38717773]
- A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder. (Am J Drug Alcohol Abuse, 2020) [PMID:31860366]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. (2018) pubmed
- Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial. (2024) pubmed
- A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder. (2020) pubmed
- Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials. (2022) pubmed
- Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder. (2022) pubmed
- Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSAT. (2018) pubmed
- Patients' perspectives on initiating treatment with extended-release naltrexone (XR-NTX). (2021) pubmed
- Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone. (2015) pubmed
- Extended-release injectable naltrexone for opioid use disorder: a systematic review. (2018) pubmed
- Extended-release buprenorphine outcomes among treatment resistant veterans. (2022) pubmed